Division of Haematology

Haematology, the study of blood, is a broad-based science encompassing pathology, immunology, molecular biology and clinical medicine. Many human diseases are directly or indirectly related to abnormalities of blood cells. We work closely with the other divisions in research and clinical service.

Head of Division Dr. Raymond SM Wong, Consultant
Clinical Staff Dr. Jones CM Chan, Associate Consultant
Dr. MF Law, Associate Consultant
Dr. Carmen KM Cheung, Resident
Dr. Tommy HC Tam, Resident
Nursing Staff Lydia WK Lam
Research Staff PN Chan
Fion YF Choy
KW Li
Mandy MT Poon
Candy LS Tsang

Research Interests

  • Autoimmune haematological diseases
  • Leukemias
  • Stem cell therapy
  • Thrombosis and anticoagulation therapy
  • Transfusion medicine

Selected Publications

  1. Cohen A, Chiu KM, Park K, Jeyaindran S, Tambunan KL, Ward C, Wong R, Yoon SS. Managing venous thromboembolism in Asia: Winds of change in the era of new oral anticoagulants. Thrombosis Research 2012;130:291-301.

  2. Rainer TH, Ho AM, Yeung JH, Cheung NK, Wong R, Tang N, Ng SK, Wong GK, Lai PB, Graham CA. Early risk stratification of patients with major trauma requiring massive blood transfusion. Resuscitation. 2011 Jun;82(6):724-9.

  3. Wong RS, Cheng CK, Chan NP, Cheng SH, Wong WS, Lau KM, Cheng G, Ng MH. JAK2 V617F mutation is associated with increased risk of thrombosis in Chinese patients with essential thrombocythaemia. British Journal of Haematology 2008;141:902-4.

  4. You JH, Zuo Z, Lo CM, Zhou L, Yiu HH, Chau CT, Choi KC, Choi DK, Wong RS, Cheng G. Any effect of CYP2C9 variants on warfarin clearance in Chinese patients? Thrombosis and Haemostasis 2007;97:866-8.

  5. Leung V, Leung V, Lui W, Chan T, Wong RS, Cheng G. Incidence of deep vein thrombosis in hospitalized Chinese medical patients is similar to that in western populations. Thrombosis Research 2006;118:763-4.

  6. Cheng Y, Cheng G, Chui CH, Lau FY, Chan PK, Ng MH, Sung JJ, Wong RS. ABO blood group and susceptibility to severe acute respiratory syndrome. The Journal of the American Medical Association 2005;293:1450-1.

  7. You JH, Chan FW, Wong RS, Cheng G. The potential clinical and economic outcomes of pharmacogenetics-oriented management of warfarin therapy - A decision analysis. Thrombosis and Haemostasis 2004;92:590-7.

  8. Wong RS, Wu A, To KF, Lee N, Lam CW, Wong CK, Chan PK, Ng MH, Yu LM, Hui DS, Tam JS, Cheng G, Sung JJ. Haematological manifestations in patients with severe acute respiratory syndrome: Retrospective analysis. British Medical Journal 2003;326:1358-62.

  9. Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. The New England Journal of Medicine 2003;349:831-6.

  10. Wong R, Lau FY, Chui CH, Tsang KS, Chik KW, Li CK, Cheng G. Transfusion of peripheral blood stem cells from donor homozygous for a shared HLA-haplotype: Avoiding fatal transfusion-associated graft-versus-host disease while preserving anti-leukemic effect. Transplantation 2001;71:487-90.